Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Government & Policy Roundup

December 20, 2004 | A version of this story appeared in Volume 82, Issue 51

Retiring Rep. W. J. (Billy) Tauzin (R-La.), 61, has been selected as the new president and CEO of the Pharmaceutical Research & Manufacturers of America. Tauzin, who did not run for reelection, succeeds Alan F. Holmer as head of the drug industry group.

Endocrine disrupter research grants of $2.25 million were announced by EPA on Dec. 14. Those awards, for work on the effects of low levels of cadmium and other chemicals that disrupt thyroid function, went to Georgetown University, Washington, D.C.; the University of Georgia, Athens; and the University of Massachusetts, Amherst.

NSF released a report detailing the trends in doctoral awards by science and engineering field and recipient characteristics, awarding institution, and recipients' postgraduate plans. The complete report, "Science and Engineering Doctorate Awards: 2003," can be viewed at http://www.nsf.gov/sbe/srs/nsf05300/start.htm.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.